Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA

Clinical Nuclear Medicine

Volumn 25, Issue 6, 2000, Pages 434-439

  Papantoniou, Vassilios ^a,b   Sotiropoulou, Maria ^a   Stipsaneli, Ekaterini ^a   Louvrou, Androniki ^a   Feda, Helen ^a   Christodoulidou, Julie ^a   Pampouras, George ^a   Zerva, Chery ^a   Keramopoulos, Antoni ^a   Michalas, Stilianos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

Author keywords

In Situ Ductal Breast Carcinoma; Tc 99m(V) DMSA, Tc 99m MIBI

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SUCCIMER TC 99M;

ADULT; ARTICLE; BREAST CALCIFICATION; CANCER DIAGNOSIS; CARCINOMA IN SITU; CASE REPORT; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; SCINTIMAMMOGRAPHY;

BREAST; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TECHNETIUM TC 99M SESTAMIBI;

EID: 0034076409     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200006000-00009     Document Type: Article

References (58)

1. Lagios MD: Human breast precancer: Current status. Cancer Surv 2:383, 1983.
2. Margolin FR, Lagios MD: Mammographic detection of early breast cancer: Ten years' experience in a community hospital. West J Med 144:46, 1986.
3. Patchefsky AS, Schwartz GF, Finkelstein SD, et al: Heterogeneity of intraductal carcinoma of the breast. Cancer 63:731, 1989.
4. Silverstein MJ, Rosser RJ, Gierson SD, et al: Axillary lymph node dissection for intraductal breast carcinoma: Is it indicated? Cancer 59:1819, 1987.
5. Michael D, Lagios MD: Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 70(4):853, 1990.
6. Verbeek ALM, Hendriks JHCL, Holland R, et al: Reduction of breast cancer mortality through mass screening with modern mammography: First results of the Nijmegen Project, 1975-1981. Lancet i:1222, 1984.
7. Baker LH: Breast cancer detection demonstration project: Fiveyear summary report. CA 32:194, 1982.
8. Meyer JE, Kopans DB, Stomper PC, Lindfors KK: Occult breast abnormalities: Percutaneous preoperative needle localization. Radiology 150:335, 1984.
9. Hall FM, Storella JM, Silverstone DZ, Wyshak G: Nonpalpable breast lesions: Recommendations for biopsy based on suspicion of carcinoma at mammography. Radiology 167:353, 1988.
10. Stomper PC, Connolly JL, Meyer JE, Harris JR: Clinically occult ductal carcinoma in situ detected with mammography: Analysis of 100 cases with radiologic-pathologic correlation. Radiology 172:235, 1989.
11. Ciatto S, Grazzini G, Iossa A, et al: In situ ductal carcinoma of the breast analysis of clinical presentation and outcome in 156 consecutive cases. Eur J Surg Oncol 16:220, 1990.
12. Dierks DB, Kary B: Lawsuits for failure to diagnose breast cancer: Tumor biology in causation and risk management strategies. Surg Oncol Clin North Am 3(1):125, 1994.
13. McKenna R: The abnormal mammogram. Radiographic findings, diagnostic options, pathology and stage of cancer diagnosis. Cancer 74:244, 1994.
14. Kao CH, Wang SJ, Liu TJ: The use of technetium-99m methoxy-isobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21:432, 1994.
15. Khalkhali I, Mena I, Jouanne E, et al: Prone scintimammography in patients with suspicion of breast cancer. J Am Coll Surg 178:491, 1994.
16. Khalkhali I, Cutrone JA, Mena I: Scintimammography: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 196:421, 1995.
17. Khalkhali I, Cutrone JA, Mena I, et al: Technetium-99m-sestamibi scintimammography of breast lesions: Clinical and pathological follow-up. J Nucl Med 36:1784, 1995.
18. Palmedo H, Grunwald F, Bender H, et al: Scintimammography with Tc-99m: Comparison with mammography and magnetic resonance imaging. Eur J Nucl Med 23:940, 1996.
19. Palmedo H, Schomburg A, Gruenwald F, et al: Scintimammography with Tc-99m MIBI in suspicious breast lesions. J Nucl Med 37:636, 1996.
20. Palmedo H, Schomburg A, Mallmann P, et al: Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer. Nucl Med Biol 23:681, 1996.
21. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J: Tc-99m MIBI prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36:1758, 1995.
22. Villanueva-Meyer J, Leonhard MH, Briscoe E, et al: Mammoscintigraphy with Tc-99m sestamibi in suspected breast cancer. J Nucl Med 37:926, 1996.
23. Tiling R. Kress K. Pechmann M, et al: Integrated diagnosis of breast tumours: Semiquantitative Tc-99m MIBI imaging versus dynamic MRI [Abstract]. J Nucl Med 35:51, 1995.
24. Burak Z, Argon M. Memis A, et al: Evaluation of palpable breast masses with Tc-99m MIBI: A comparative study with mammography and ultrasonography. Nucl Med Commun 15:604, 1994.
25. Kahlkahli I, Mena I, Jouanne E, et al: Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 178:491, 1994.
26. Tolmos J, Cutrone JA, Wang B, et al: Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. J Natl Cancer Inst 90:846, 1998.
27. Marzetti L, Paolucci A, Porfiri LM, et al: Breast scintigraphy with 99m Tc-MIBI in the study of breast cancer. Minerva Ginecol 50:15, 1998.
28. Scopinaro F, Mezi S, Ierardi M, et al: 99mTc-MIBI prone scintimammography in patients with suspicious breast cancer. Relationship with mammography and tumor size. Int J Oncol 12: 661, 1998.
29. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E: Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med 39:86, 1998.
30. Papantoniou V, Karganzis P, Stipsanelli A, et al: Technetium-99m (V) dimercaptosuccinic acid [Tc-99m (V) DMSA] in the detection of primary breast cancer [Abstract]. Preliminary results. Eur J Nucl Med 23:1216, 1996.
31. Papantoniou V, Stipsanelli A, Arka A, et al: Comparison of technetium-99m [V]-DMSA with technetium-99m-MDP in diagnosis of breast lesions [Abstract]. Eur J Nucl Med 25:1040, 1998.
32. Papantoniou V, Stipsanelli A, Galeros C, et al: Similarity between Tc-99m-V-DMSA and Tc-99m sestamibi in the detection of primary breast cancer [Abstract]. Preliminary results. Eur J Nucl Med 25:1040, 1998.
33. Papantoniou V, Stipsaneli A, Arka A, et al: Immunohistologic assessment of Tc-99m-(V)DMSA and Tc-99m-MIBI uptake in breast cancer. Eur J Nucl Med 26:977, 1999.
34. Papantoniou V, Stipsaneli A, Louvrou A, et al: Histology and grade of malignancy are factors affecting Tc-99m-MIBI and Tc-99m(V)DMSA uptake and Washout in breast cancer. Eur J Nucl Med 26:1163, 1999.
35. Papantoniou V, Stipsaneli A, Feida H, et al: Comparison of Tc-99m-MIBI and Tc-99m (V)DMSA scintimammography in the detection of breast cancer and axillary lymph node involvement. Eur J Nucl Med 26:1163, 1999.
36. Dershaw DD, Adramson A, Kinne D: Ductal carcinoma in situ: Mammographic findings and clinical implications. Radiology 170:411, 1989.
37. Ikeda DM, Andersson I: Atypical mammographic presentations of ductal carcinoma in situ. Radiology 172:661, 1999.
38. Betsill WL Jr, Rosen PP, Lieverman PH, et al: Intraductal carcinoma: Long-term follow-up after treatment by biopsy alone. JAMA 239:1863, 1978.
39. Page DL, Winfield AC: The dense mammogram [Editorial]. AJR 147:487, 1986.
40. Jackson VP, Hendrick RE, Kerg SA, et al: Imaging of the radiographically dense breast. Radiology 1983:297, 1993.
41. Johnson LV, Walsh ML, Bockus BJ, Chen LB: Monitoring of relative mitochondrial membrane potential in living cells by fluorescence relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol 88:526, 1981.
42. Summerhayer IC, Lampidis TJ, Bernai SD, et al: Unusual retention of rhodamine-123 by mitochondria in muscle and carcinoma cells. Proc Natl Acad Sci USA 79:5292, 1982.
43. Nadakavukaren KK, Nadakavukaren JJ, Chen LB: Increased rhodamine-123 uptake by carcinoma cells. Cancer Res 45:6093, 1985.
44. Delmon-Moingeon LI, Picwnica-Worms D, Van den Abbeele AD, et al: Uptake of the cation hexakjis (2-methoxyisobutyl-isonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 50:2198, 1990.
45. Picwnica-Worms D, Chiu ML, Budding M, et al: Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53:977, 1993.
46. Endo K, Ohta H, Sakahara H, et al: Distinctive behaviour of 99m-Tc (V) dimercaptosuccinic acid as a tumour seeking agent. Vienna: IAEA, 1985, pp 201-209.
47. Watkinson JC, Allen S, Lazarus CR, et al: Pharmacokinetics, biodistribution and dosimetry of 99-Tc-(V)DMSA in humans with squamous cell carcinoma. Nucl Med Commun 11:343, 1990.
48. Guerra U, Pizzocaro C, Terzi A, Giubbini R, Bestagno M: The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC). Journal of Nuclear Medicine and Allied Sciences 32:242, 1988.
49. Monsieur I, Meysman M, Noppen M, et al: Non-small-cell lung cancer with multiple paraneoplastic syndromes. Eur Respir J 8:1231, 1995.
50. Harrison TR. Principles of Internal Medicine, Vol. B, 10th ed. Athens: Parisianos, 1987, pp 988-992.
51. Egerton M, Needham M, Evans S, et al: Identification of multiple human calcitonin receptor isoforms: Heterologous expression and pharmacological characterization. J Mol Endocrinol 14: 179, 1995.
52. Clifford EJ, Lugo-Zamudio C: Scintimammography in the Diagnosis of Breast Cancer. Am J Surg 172:483, 1996.
53. Papantoniou V: Role of 99m-Tc-(V)DMSA in breast imaging [Letter to the Editor]. Eur J Nucl med 25:547, 1998.
54. Cutrone JA, Yospur LS, Khalkhali I, et al: Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med 39:449, 1998.
55. Hove M, Leonard MH, Villanueva-Mayer J, Cown DF: Histopathologic correlates of 99m-Tc-sestamibi scanning in the breast [Abstract]. Mod Pathol 19: 1995.
56. Howarth DM, Sillar R, Lan L: Tc-99m sestamibi scintimammography: The influence of lesion size and its role in the detection of pre-invasive breast cancer. Proceedings of the 46th Annual Meeting. J Nucl Med 40:16P, 1999.
57. Disa J, Dang K, Tan KB, Aiyar N: Interaction of adrenomedullin with calcitonin receptor in cultured human breast cancer cells, T 470. Peptides 19:247, 1998.
58. Zimmermann U, Fluehmann B, Born W, Fischer JA, Muff R: Coexistence of novel-amylin-binding sites with calcitonin receptors in human breast carcinoma MCF-7 cells. J Endocrinol 155:423, 1997.